KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
24,50 $
0,00%
(0,00) 1D
1 қаз., 10:21:43 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
176,86 млрд
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 $
52-wk low
24,50 $
Beta
13,94
Shares outstanding
46,54 млн
No. of employees
2 мың
Mkt. cap
176,86 млрд
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 $
52-wk low
24,50 $
Beta
13,94
Shares outstanding
46,54 млн
No. of employees
2 мың
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
29 минут бұрын
A screen shows the logo and a ticker symbol for The Walt Disney Company on the floor of the New York Stock Exchange (NYSE) in New York
MarketBeat
·
10 минут бұрын
Wall Street Zen Upgrades Radware (NASDAQ:RDWR) to Buy
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,79 мың
Founded1946 ж. 09 там.
HeadquartersMatsumoto, Nagano, Жапония
SectorPharmaceutical industry
Websitekissei.co.jp